Article Versions Notes

Reus P, Schneider A-K, Ulshöfer T, Henke M, Bojkova D, Cinatl J, Ciesek S, Geisslinger G, Laux V, Grättinger M, et al. Characterization of ACE Inhibitors and AT₁R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model. Life. 2021; 11(8):810. https://doi.org/10.3390/life11080810

Reus, Philipp, Ann-Kathrin Schneider, Thomas Ulshöfer, Marina Henke, Denisa Bojkova, Jindrich Cinatl, Sandra Ciesek, Gerd Geisslinger, Volker Laux, Mira Grättinger, and et al. 2021. "Characterization of ACE Inhibitors and AT₁R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model" Life 11, no. 8: 810. https://doi.org/10.3390/life11080810

Reus, P., Schneider, A.-K., Ulshöfer, T., Henke, M., Bojkova, D., Cinatl, J., Ciesek, S., Geisslinger, G., Laux, V., Grättinger, M., Gribbon, P., & Schiffmann, S. (2021). Characterization of ACE Inhibitors and AT₁R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model. Life, 11(8), 810. https://doi.org/10.3390/life11080810